Impact of obesity on the efficacy of different biologic agents in inflammatory diseases: a systematic review and meta-analysis
ConclusionObesity hampered the effect of anti-TNF agents, but not those of abatacept and tocilizumab, suggesting that a personalized treatment strategy should be considered for obese patients with inflammatory diseases.
Source: Joint Bone Spine - Category: Orthopaedics Source Type: research
More News: Abatacept | Actemra | Arthritis | Crohn's Disease | Databases & Libraries | Eating Disorders & Weight Management | Epidemics | Epidemiology | Inflammatory Bowel Disease | Obesity | Orencia | Psoriasis | Rheumatoid Arthritis | Rheumatology | Rituxan